BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25240632)

  • 1. Safety of a nasal vaccine against Streptococcus pneumoniae using heat-killed Lactobacillus casei as adjuvant.
    Almada G; Haro C; Vintiñi E; Medina M
    Immunobiology; 2015 Jan; 220(1):109-16. PubMed ID: 25240632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
    Vintiñi EO; Medina MS
    BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei.
    Villena J; Barbieri N; Salva S; Herrera M; Alvarez S
    Microbiol Immunol; 2009 Nov; 53(11):636-46. PubMed ID: 19903264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.
    Hernani Mde L; Ferreira PC; Ferreira DM; Miyaji EN; Ho PL; Oliveira ML
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):263-72. PubMed ID: 21492260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
    Xu X; Meng J; Wang Y; Zheng J; Wu K; Zhang X; Yin Y; Zhang Q
    J Microbiol; 2014 Apr; 52(4):315-23. PubMed ID: 24682994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
    Campos IB; Darrieux M; Ferreira DM; Miyaji EN; Silva DA; Arêas AP; Aires KA; Leite LC; Ho PL; Oliveira ML
    Microbes Infect; 2008 Apr; 10(5):481-8. PubMed ID: 18403234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
    Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
    PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine.
    Jwa MY; Jeong S; Ko EB; Kim AR; Kim HY; Kim SK; Seo HS; Yun CH; Han SH
    J Microbiol; 2018 Aug; 56(8):579-585. PubMed ID: 30047087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of a non-viable Lactobacillus casei to infant mice modulates lung damage induced by Poly I:C and hyperreactivity in airways.
    Vintiñi E; Haro C; Palazon E; Medina M
    Microbes Infect; 2022 Sep; 24(6-7):104997. PubMed ID: 35533988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
    Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
    Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
    Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
    Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
    PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
    Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
    Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
    Medina M; Villena J; Salva S; Vintiñi E; Langella P; Alvarez S
    Microbiol Immunol; 2008 Aug; 52(8):399-409. PubMed ID: 18667039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.